top of page

Positive CHMP opinion for Gilead’s Epclusa in HCV

The EMA’s Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion onGilead’s Epclusa for the treatment of chronic hepatitis C virus (HCV).

Click on this link for more information.



Today's News
Follow us
  • LinkedIn Social Icon
  • Vimeo Social Icon
Newsletter on Pharma Legislation
the newsletter of
bottom of page